🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 17 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/11/2000 | 55,21 | 58,02 | 55,21 | 57,55 | +3,80% | 5,08% | 61.609 |
| 01/11/2000 | 54,51 | 57,55 | 52,40 | 55,44 | -0,42% | 9,44% | 86.562 |
| 31/10/2000 | 51,70 | 56,14 | 50,53 | 55,68 | +5,78% | 10,86% | 59.338 |
| 30/10/2000 | 53,34 | 54,27 | 51,47 | 52,64 | -0,88% | 5,26% | 48.517 |
| 27/10/2000 | 55,21 | 55,68 | 53,10 | 53,10 | -3,81% | 4,66% | 41.705 |
| 26/10/2000 | 53,10 | 55,91 | 50,06 | 55,21 | +2,61% | 11,01% | 66.551 |
| 25/10/2000 | 54,27 | 54,74 | 51,47 | 53,81 | +0,00% | 6,03% | 47.395 |
| 24/10/2000 | 57,61 | 61,06 | 53,34 | 53,81 | -6,50% | 13,40% | 89.421 |
| 23/10/2000 | 53,81 | 59,65 | 52,17 | 57,55 | +6,49% | 13,91% | 97.543 |
| 20/10/2000 | 51,93 | 54,51 | 49,13 | 54,04 | +5,00% | 10,36% | 51.750 |
| 19/10/2000 | 52,17 | 52,87 | 49,59 | 51,47 | -0,90% | 6,28% | 30.778 |
| 18/10/2000 | 50,30 | 52,40 | 46,79 | 51,93 | +3,26% | 11,16% | 60.994 |
| 17/10/2000 | 51,23 | 51,93 | 50,06 | 50,30 | -1,38% | 3,65% | 31.232 |
| 16/10/2000 | 50,06 | 52,40 | 48,66 | 51,00 | +5,83% | 7,48% | 67.299 |
| 13/10/2000 | 46,09 | 48,19 | 44,21 | 48,19 | +5,10% | 8,63% | 56.613 |
| 12/10/2000 | 47,72 | 51,23 | 45,15 | 45,85 | -4,39% | 12,75% | 72.723 |
| 11/10/2000 | 51,00 | 51,41 | 46,09 | 47,96 | -7,24% | 10,44% | 58.216 |
| 10/10/2000 | 50,53 | 52,64 | 50,06 | 51,70 | +1,38% | 5,09% | 47.449 |
| 09/10/2000 | 51,47 | 51,70 | 49,83 | 51,00 | -1,80% | 3,64% | 59.819 |
| 06/10/2000 | 52,40 | 55,68 | 51,00 | 51,93 | -1,77% | 8,93% | 117.633 |
| 05/10/2000 | 50,06 | 53,34 | 49,59 | 52,87 | +5,61% | 7,48% | 129.603 |
| 04/10/2000 | 47,72 | 50,30 | 47,26 | 50,06 | +3,38% | 6,37% | 84.318 |
| 03/10/2000 | 48,19 | 50,53 | 48,19 | 48,42 | -1,43% | 4,85% | 55.197 |
| 02/10/2000 | 48,19 | 49,59 | 47,96 | 49,13 | +2,44% | 3,40% | 74.994 |
| 29/09/2000 | 47,61 | 49,59 | 47,26 | 47,96 | -3,76% | 4,91% | 42.453 |
| 28/09/2000 | 47,02 | 49,83 | 46,55 | 49,83 | +6,50% | 6,97% | 62.918 |
| 27/09/2000 | 45,62 | 47,72 | 44,92 | 46,79 | +4,17% | 6,15% | 52.285 |
| 26/09/2000 | 47,26 | 49,83 | 44,68 | 44,92 | -4,95% | 10,89% | 51.590 |
| 25/09/2000 | 50,76 | 51,23 | 45,85 | 47,26 | -2,88% | 10,60% | 49.105 |
| 22/09/2000 | 42,11 | 49,59 | 41,87 | 48,66 | +0,97% | 18,33% | 70.933 |